Thromboxane A2 inhibition: therapeutic potential in bronchial asthma (Q34289502)

1 August 2017

1 reference

title

Thromboxane A2 inhibition: therapeutic potential in bronchial asthma (English)

1 reference

1 August 2017

0 references

Jean-Michel Dogné

1 reference

1 August 2017

Xavier de Leval

1 reference

1 August 2017

Patricia Benoit

1 reference

1 August 2017

Jacques Delarge

1 reference

1 August 2017

Bernard Masereel

1 reference

1 August 2017

publication date

1 January 2002

1 reference

Treatments in Respiratory Medicine

1 August 2017

published in

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

11-17

1 reference

Thromboxane A2 and related prostaglandins in airways

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Discovery of leukotrienes and development of antileukotriene agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Role of leukotrienes in asthma pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Biochemistry and physiology of the leukotrienes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Leukotriene receptor antagonists in the treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Efficacy of antileukotriene agents in asthma management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Arachidonic acid metabolism by human monocytes. Studies with platelet-depleted cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Thromboxane A2: effects on airway and vascular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Effect of inhibition of thromboxane production on the leukotriene D4-mediated bronchoconstriction in the guinea pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Inhibitory effect of a thromboxane A2 synthetase inhibitor OKY-046 on bronchial hyperresponsiveness to histamine, but not on airway wall thickening, induced by intravenous administration of leukotriene C4 in guinea-pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Possible involvement of thromboxane in bronchoconstrictive and hypertensive effects of LTC4 and LTD4 in guinea pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Role of thromboxane A2 synthetase inhibitors in the treatment of patients with bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Effects of aerosol administration of a thromboxane synthetase inhibitor (OKY-046) on bronchial responsiveness to acetylcholine in asthmatic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Effect of a thromboxane A2 receptor antagonist (AA-2414) on bronchial hyperresponsiveness to methacholine in subjects with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Effect of an inhaled thromboxane mimetic (U46619) on airway function in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Effect of BAY u3405, a thromboxane A2 receptor antagonist, on neuro-effector transmission in canine tracheal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Secondary release of thromboxane A2 in aerosol leukotriene C4-induced bronchoconstriction in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Pharmacological studies of platelet-activating factor (PAF)-induced augmentation of response to histamine in guinea-pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Involvement of arachidonate cyclooxygenase products in bronchial hyperresponsiveness induced by subthreshold concentration of aerosolized thromboxane A2 analogue (STA2) in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Effect of a thromboxane A2 synthetase inhibitor (OKY-046.HCl) on airway hyperresponsiveness in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

A novel anti-asthmatic quinone derivative, AA-2414 with a potent antagonistic activity against a variety of spasmogenic prostanoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Quinones. 4. Novel eicosanoid antagonists: synthesis and pharmacological evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Synthesis and thromboxane A2/prostaglandin H2 receptor antagonistic activity of phenol derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Antagonism of the human thromboxane A2 receptor by an anti-asthmatic agent AA-2414.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane A2 receptor antagonist (AA-2414) in Ascaris suum-allergic dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

BAY u3405 is a potent and competitive antagonist of U46619, PGD2 and 9 alpha, 11 beta PGF2 alpha-induced contractions of airway smooth muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Inhibitory effects of BAY u3405 on prostanoid-induced contractions in human isolated bronchial and pulmonary arterial muscle preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

BAY u3405 an antagonist of thromboxane A2- and prostaglandin D2-induced bronchoconstriction in the guinea-pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

BAY u3405, a potent and selective thromboxane A2 receptor antagonist on airway smooth muscle in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

The Thromboxane Receptor Antagonist BAY u3405 Reverses Prostaglandin D2(PGD2)-Induced Bronchoconstriction in the Anaesthetised Guinea Pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Effects of a thromboxane-receptor antagonist, BAY u 3405, on prostaglandin D2- and exercise-induced bronchoconstriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

The effects of an oral thromboxane TP receptor antagonist BAY u 3405, on prostaglandin D2- and histamine-induced bronchoconstriction in asthma, and relationship to plasma drug concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Effect of thromboxane A2 (TXA2) synthase inhibitor and TXA2 receptor antagonist alone and in combination on antigen-induced bronchoconstriction in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

Effect of YM158, a dual lipid mediator antagonist, on immediate and late asthmatic responses, and on airway hyper-responsiveness in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

In vivo pharmacologic profile of YM158, a new dual antagonist for leukotriene D4 and thromboxane A2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257158

21 January 2018

Identifiers

DOI

10.1007/BF03257158

1 reference

1 August 2017

1 reference